Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...

The scientist studies data on gender identity and sexual orientation. Here’s why that’s vital for cancer research and health ...

Preventing the cell’s protein factories from making the cancer-causing protein MYC could stop out-of-control tumors.

Those who were treated with celecoxib, a non-steroidal anti-inflammatory drug, experienced significantly improved ...

Spend billions of dollars to cover anti-obesity drugs under Medicare and Medicaid, or deny more than 7 million people access ...

Emerging technologies should supplement, not replace, personalized care, notes a report from the President’s Cancer Panel.

Disruptions to government data could compromise understanding of cancer burden, emerging trends and effective interventions ...

Dana-Farber researchers sought to learn more about what factors contribute to the success of donor lymphocyte infusion, a ...

If the Trump administration succeeds in shutting down the federal United States Agency for International Development, known ...

There’s a lack of research on whether cat biology makes them more susceptible to H5N1 than other mammals, including humans, ...

Scientists transformed energy-storing white fat cells into calorie-burning "beige" fat cells that outcompeted tumors for ...

A customized kidney cancer vaccine made from patients’ tumors was well tolerated and appeared promising in a small study, according to findings published in Nature.These early findings add to the ...